Thursday, September 3, 2015

16:30-16:45
 Welcome remarks
16:45-18:45
Gene therapy
Chairperson
Amos Panet, Israel

 16:45

Genetic manipulation of solid tissues ex vivo for the sustain production of therapeutic proteins after implantation in patients 
Amos Panet, Israel

 17:15

Treating nervous system tumors with herpes simplex virus
Samuel Rabkin, USA

 17:45

Gene therapy for hereditary leukodystrophies
Nathalie Cartier, France

 18:15

The promise and obstacles of gene therapy in muscular dystrophies
Thomas Voit, France
18:45-19:30 Keynote lecture
 
Genetic enhancements in normal health-eugenics
Anjan Chatterjee, USA

19:30-20:30

Networking Reception


Friday, September 4, 2015

08:30-12:20
Animal models as a vehicle to evaluate therapeutic effect
in neurological diseases

Chairperson

Israel Steiner, Israel
 08:30
Multiple Sclerosis
Subramaniam Sriram, USA
 08:55
Stroke
Michael Chopp, USA
 09:20
Parkinson’s disease
Olaf Riess, Germany
 09:45
Diseases of the synapse: Novel clinical paradigms, models of disease, and therapeutic implications
Josep Dalmau, Spain
10:10-10:40 Coffee break and poster viewing 
 10:40
Muscle disease
Mayana Zatz,
Brazil
 11:05
Alzheimer’s disease
Manfred Windisch, Austria 
 11:30 Ataxia 
Helen Puccio, France
 11:55 How do regulators view animal models?
Marlene Haffner,
 USA

12:20-13:00
 
Discussion: 
Animal models: Should we continue to rely solely on them in developing therapies? 
 
 Chairpersons 
 
 
Zohar Argov, Israel
Israel Steiner, Israel 
 Panelists
Subramaniam Sriram, USA
Michael Chopp, USA
Olaf Riess, Germany
Josep Dalmau, Spain
Mayana Zatz, Brazil
Manfred Windisch, Austria 
Helen Puccio, France
Marlene Haffner, USA
 
 
13:00-14:00        
Lunch break and poster viewing
14:00-16:30
Movement disorders and behavioural neurology

Chairperson

Elio Scarpini, Italy

 14:00

Dementia: If and how to treat psycho-behavioural disturbances 
Alfredo Carlo Altamura, Italy

 14:30

The treatment of extra nigral symptomatology involvement in Parkinson's disease
Ivan Rektor, Czech Republic

15:00-15:30

Coffee break and poster viewing 

 15:30

The diagnosis and treatment of FTD 
Yolande Pijnenburg, The Netherlands

 16:00

The perspectives of new disease-modifying strategies 
Elio Scarpini, Italy

16:30-17:15
Round Table Discussion: Therapy of orphan neurological diseases

Chairperson

Zohar Argov,  Israel

16:30
16:40
16:50
17:00

John Richert, USA 
Marlene Haffner, USA  
Paul Matthews, UK 
Discussion

17:15-18:00 The provocation of the day
 

Regulatory balance: Are we impeding neurological research?
Efrat Levi-Lahad, Israel

 


Saturday, September 5, 2015

08:30-09:20
Round Table Discussion: Length of Multiple Sclerosis pivotal studies
Chairperson
Israel Steiner, Israel
 08:30
08:40
08:50
09:00
Nancy Richert, USA
Ludwig Kappos, Switzerland 
David Leppert, Switzerland
Discussion

 09:20-10:00
Round Table Discussion: Informed consent in Alzheimer's disease and other dementing conditions
 Chairperson Israel Steiner, Israel 
 09:20
09:30
09:40
Anjan Chatterjee, USA
Efrat Levi-Lahad
, Israel 
Discussion
10:00-10:30
Coffee break and poster viewing

10:30-12:30
Neuro infections
Chairperson
Avindra Nath, USA
 10:30
Therapy of lyme and post lyme disease syndrome  
Andrew Pachner, USA 
 11:00
PML: Prevention, diagnosis and therapy
Nancy Richert, USA
 11:30
Issues in the treatment of neurological conditions caused by reactivation of Varicella-Zoster Virus (VZV) 
Peter Kennedy, UK
 12:00
Therapy of neuroAIDS
Avindra Nath, USA

12:30-13:00
Free Communications
12:30-12:45 A double-blind, randomized, versus-placebo study, in order to evaluate efficacy of the ultra-micronized palmitoylethanolamide in reducing interferonb-1A related side effects in relapsing remitting Multiple Sclerosis 
Nicola Salvatore Orefice, Italy
  Discussant: Moses Rodriguez, USA
12:45-13:00 Brain-derived neurotrophic factor (BDNF) enhance therapeutic effects of human adipose stem cells (ADSC) in ALS rat model
Hong J. Lee, Korea
  Discussant: Amos Panet, Israel
13:00-14:00  Lunch break and poster viewing

14:00-17:30
Future neurotherapeutics

Chairperson

Louis Caplan, USA
14:00
Multiple sclerosis
Moses Rodriguez, USA
 14:30
Stroke
Louis Caplan, USA
 15:00 Infections
David Clifford
, USA 
 15:30 Peripheral neuropathies
David Cornbalth, USA
16:00-16:15 Coffee break and poster viewing
 16:15 Alzheimer's disease
Nathalie Cartier, France
 16:45 The near future of neurotherapeutics in headache disorders
Morris Levin, USA
 17:15 Cerebellar ataxias
Massimo Pandolfo, Belgium

17:45-18:30

Sunday, September 6, 2015

8:30-12:00

Management dilemmas in neuroimmunological conditions

Chairperson
Nicola De Stefano, Italy
 8:30
Multiple sclerosis: What to do with the patient with no evidence for disease activity
Nicola De Stefano, Italy
 9:00
Acute myelitis and NMO: What is the right treatment?
Brian Weinshenker, USA
 9:30
Primary CNS vasculitis: Challenges in diagnosis and treatment
Nicolo Pipitone, Italy
10:00-10:30
Coffee break and poster viewing
 10:30
Thymectomy in MG
Gil Wolfe, USA
 11:00
Necrotizing autoimmune myopathy
Marianne De Visser, The Netherlands
 11:30
Treatment dilemmas for multifocal motor neuropathy without conduction blocks
David Cornblath, USA
12:00-12:30
Summary and closure
Presentation of Young Scientist Award